Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
OBJECTIVE The aim was to update The Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published in 2006. CONSENSUS PROCESS Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails. An initial draft was prepared by the Task Force, with the help of a medical writer, and reviewed and commented on by members of The Endocrine Society. A second draft was reviewed and approved by The Endocrine Society Council. At each stage of review, the Task Force received written comments and incorporated substantive changes. CONCLUSIONS GHD can persist from childhood or be newly acquired. Confirmation through stimulation testing is usually required unless there is a proven genetic/structural lesion persistent from childhood. GH therapy offers benefits in body composition, exercise capacity, skeletal integrity, and quality of life measures and is most likely to benefit those patients who have more severe GHD. The risks associated with GH treatment are low. GH dosing regimens should be individualized. The final decision to treat adults with GHD requires thoughtful clinical judgment with a careful evaluation of the benefits and risks specific to the individual.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GHD in particular has a wide range of test methodology and diagnostic thresholds employed across studies, despite agreement among global guidelines [26 · , 64-67] as to what constitutes deficiency.”
From Neuroendocrine Disruptions Following Head Injury (2023) · cites this paper as [65]
In the citing paper
“For the diagnosis of TBI-induced GHD, the ITT and the GHRHϩARG test are now considered as the tests of choice with similar accuracy (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“The glucagon stimulation test (GST) (1 mg glucagon im, GH measurements every 30 min until 240 min after administration) has been proposed as an alternative diagnostic because it is able to differentiate between GH-deficient and healthy subjects with a sensitivity and specificity of 100% if a peak GH of 3 g/L is considered (215, 226).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“For the ITT, peak GH response levels lower than 3 g/L indicate severe GHD in adults (if hypoglycemia is adequately reached) (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“Therefore, in the latest Endocrine Society guideline on the evaluation and treatment of adult GHD, as part of their standard clinical care, patients with severe GHD (diagnosed by appropriate dynamic tests and with relevant clinical features) were recommended individualized physiological doses of recombinant GH treatment (215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis
Rogers, L., Shetter, A. G., Ponce, F. A., Fiedler, J. A., Smith, K. A., & Speiser, B. L. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.supplement_5.0529 · Cited by 1,773
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“hypogonadal men received testosterone replacement (154).”
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Hodis, H. N., Mack, W. J., LaBree, L., Selzer, R. H., Liu, C.-R., Liu, C.-H., & Azen, S. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00002 · Cited by 1,217 · cited 1×
“In epidemiological studies, increases in IMT have predicted the development of symptomatic coronary disease occurring approximately 8 yr after the initial measurements (137).”
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jørgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jørgensen, I., Skakkebaek, N. E., & Christiansen, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92328-3 · Cited by 890
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Self-citationTreatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson, B. A., Edén, S., Lönn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L., & Isaksson, O. G. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432773 · Cited by 778
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
Cited by
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Giustina, A., Mazziotti, G., & Canalis, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 914
Grimberg, A., DiVall, S. A., Polychronakos, C., Allen, D. B., Cohen, L. E., Quintos, J. B., Rossi, W. C., Feudtner, C., Murad, M. H., & on behalf of the Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society (2016) · Hormone Research in Paediatrics · doi:10.1159/000452150 · Cited by 697
Lipshultz, S. E., Adams, M. J., Colan, S. D., Constine, L. S., Herman, E. H., Hsu, D. T., Hudson, M. M., Kremer, L. C., Landy, D. C., Miller, T. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182a88099 · Cited by 612
Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings
Angulo, M. A., Butler, M. G., & Cataletto, M. E. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0312-9 · Cited by 601
Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline
Freda, P. U., Beckers, A. M., Katznelson, L., Molitch, M. E., Montori, V. M., Post, K. D., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1048 · Cited by 585
Self-citationEndocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
Chang, L.-S., Barroso-Sousa, R., Tolaney, S. M., Hodi, F. S., Kaiser, U. B., & Min, L. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00006 · Cited by 532
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
Clemmons, D. R. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.150631 · Cited by 353
Self-citationGrowth hormone — past, present and future
Ranke, M. B., & Wit, J. M. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.22 · Cited by 346
Yuen, K. C. J., Biller, B. M. K., Radovick, S., Carmichael, J. D., Jasim, S., Pantalone, K. M., & Hoffman, A. R. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0405 · Cited by 298
Chemaitilly, W., Li, Z., Huang, S., Ness, K. K., Clark, K. L., Green, D. M., Barnes, N., Armstrong, G. T., Krasin, M. J., Srivastava, D. K., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.7933 · Cited by 281
Rich-Edwards, J. W., Kaiser, U. B., Chen, G. L., Manson, J. E., & Goldstein, J. M. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00246 · Cited by 273
Higham, C. E., Johannsson, G., & Shalet, S. M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30053-8 · Cited by 267
The metabolic syndrome in cancer survivors
de Haas, E. C., Oosting, S. F., Lefrandt, J. D., Wolffenbuttel, B. H., Sleijfer, D. T., & Gietema, J. A. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70287-6 · Cited by 234
Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1065 · Cited by 218
Glucocorticoids and the regulation of growth hormone secretion
Mazziotti, G., & Giustina, A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.5 · Cited by 206
Nonfunctioning Pituitary Tumors and Pituitary Incidentalomas
Molitch, M. E. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.011 · Cited by 204
Self-citationNeurotrophic and Neuroregenerative Effects of GH/IGF1
Bianchi, V., Locatelli, V., & Rizzi, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112441 · Cited by 202
Growth Hormone Deficiency: Health and Longevity
Aguiar-Oliveira, M. H., & Bartke, A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00216 · Cited by 197
Testosterone and Growth Hormone Improve Body Composition and Muscle Performance in Older Men
Sattler, F. R., Castaneda-Sceppa, C., Binder, E. F., Schroeder, E. T., Wang, Y., Bhasin, S., Kawakubo, M., Stewart, Y., Yarasheski, K. E., Ulloor, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2338 · Cited by 194
Mazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
Cook, D. M., Yuen, K. C. J., Biller, B. M. K., Kemp, S. F., Vance, M. L., Cook, D. M., Yuen, K. C. J., Biller, B. M. K., Kemp, S. F., Vance, M. L., et al. (2009) · Endocrine Practice · doi:10.4158/ep.15.s2.1 · Cited by 179
Self-citationNon-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management
Esposito, D., Olsson, D. S., Ragnarsson, O., Buchfelder, M., Skoglund, T., & Johannsson, G. (2019) · Pituitary · doi:10.1007/s11102-019-00960-0 · Cited by 177
Nishizawa, H., Iguchi, G., Murawaki, A., Fukuoka, H., Hayashi, Y., Kaji, H., Yamamoto, M., Suda, K., Takahashi, M., Seo, Y., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0252 · Cited by 178
Pathogenesis and Diagnosis of Growth Hormone Deficiency in Adults
Melmed, S. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1817346 · Cited by 173
Pokrajac, A., Wark, G., Ellis, A. R., Wear, J., Wieringa, G. E., & Trainer, P. J. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02836.x · Cited by 172
IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner
Nishizawa, H., Iguchi, G., Fukuoka, H., Takahashi, M., Suda, K., Bando, H., Matsumoto, R., Yoshida, K., Odake, Y., Ogawa, W., et al. (2016) · Scientific Reports · doi:10.1038/srep34605 · Cited by 164
Review: Traumatic brain injury and hyperglycemia, a potentially modifiable risk factor
Shi, J., Dong, B., Mao, Y., Guan, W., Cao, J., Zhu, R., & Wang, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11958 · Cited by 162
Late endocrine effects of childhood cancer
Rose, S. R., Horne, V. E., Howell, J. C., Lawson, S. A., Rutter, M. M., Trotman, G. E., & Corathers, S. D. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.45 · Cited by 168
Radiation-induced hypopituitarism after cancer therapy: who, how and when to test
Darzy, K. H. (2009) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet1051 · Cited by 171
“1 µg/l has since been recommended by the US Endocrine Society”
MethodMortality and morbidity in adult craniopharyngioma
Erfurth, E. M., Holmer, H., & Fjalldal, S. B. (2012) · Pituitary · doi:10.1007/s11102-012-0428-2 · Cited by 163
Mauras, N., Gonzalez de Pijem, L., Hsiang, H. Y., Desrosiers, P., Rapaport, R., Schwartz, I. D., Klein, K. O., Singh, R. J., Miyamoto, A., & Bishop, K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1559 · Cited by 151
Gazzaruso, C., Gola, M., Karamouzis, I., Giubbini, R., & Giustina, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2394 · Cited by 151
Diagnosis of growth hormone deficiency in childhood
Stanley, T. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32834ec952 · Cited by 148
Growth Hormone’s Links to Cancer
Boguszewski, C. L., & Boguszewski, M. C. D. S. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00166 · Cited by 146
Elbornsson, M., Gotherstrom, G., Bosaeus, I., Bengtsson, B.-A., Johannsson, G., & Svensson, J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1072 · Cited by 144
Friedrich, N., Wolthers, O. D., Arafat, A. M., Emeny, R. T., Spranger, J., Roswall, J., Kratzsch, J., Grabe, H. J., Hübener, C., Pfeiffer, A. F. H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3060 · Cited by 154
The management of osteoporosis in children
Ward, L. M., Konji, V. N., & Ma, J. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3515-9 · Cited by 151
Bihan, H., Christozova, V., Dumas, J., Jomaa, R., Valeyre, D., Tazi, A., Reach, G., Krivitzky, A., & Cohen, R. (2007) · Medicine · doi:10.1097/md.0b013e31815585aa · Cited by 136
Hormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132
Bando, H., Iguchi, G., Fukuoka, H., Taniguchi, M., Yamamoto, M., Matsumoto, R., Suda, K., Nishizawa, H., Takahashi, M., Kohmura, E., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0642 · Cited by 130
A comprehensive diagnostic approach to detect underlying causes of obesity in adults
van der Valk, E. S., van den Akker, E. L. T., Savas, M., Kleinendorst, L., Visser, J. A., Van Haelst, M. M., Sharma, A. M., & van Rossum, E. F. C. (2019) · Obesity Reviews · doi:10.1111/obr.12836 · Cited by 129
Long-Acting Growth Hormone Preparations – Current Status and Future Considerations
Miller, B. S., Velazquez, E., & Yuen, K. C. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz149 · Cited by 125
Bidlingmaier, M., & Freda, P. U. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2009.09.005 · Cited by 124
Increasing Enzyme Stability and Activity through Hydrogen Bond-Enhanced Halogen Bonds
Carlsson, A.-C. C., Scholfield, M., Rowe, R. K., Ford, M. C., Alexander, A. T., Mehl, R., & Ho, P. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00603 · Cited by 99
Lonardo, A., Mantovani, A., Lugari, S., & Targher, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112841 · Cited by 120
Adult growth hormone deficiency - benefits, side effects, and risks of growth hormone replacement
Reed, M. L., Merriam, G. R., & Kargi, A. Y. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00064 · Cited by 119
Self-citationMinireview: Mechanisms of Growth Hormone-Mediated Gene Regulation
Chia, D. J. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1099 · Cited by 132
Aguiar-Oliveira, M. H., Oliveira, F. T., Pereira, R. M. C., Oliveira, C. R. P., Blackford, A., Valenca, E. H. O., Santos, E. G., Gois-Junior, M. B., Meneguz-Moreno, R. A., Araujo, V. P., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1879 · Cited by 118
Boguszewski, M. C. S., Boguszewski, C. L., Chemaitilly, W., Cohen, L. E., Gebauer, J., Higham, C., Hoffman, A. R., Polak, M., Yuen, K. C. J., Alos, N., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1186 · Cited by 117
GH/IGF-I Regulation in Obesity – Mechanisms and Practical Consequences in Children and Adults
Kreitschmann-Andermahr, I., Suarez, P., Jennings, R., Evers, N., & Brabant, G. (2010) · Hormone Research in Paediatrics · doi:10.1159/000284355 · Cited by 117
Macimorelin as a Diagnostic Test for Adult GH Deficiency
Garcia, J. M., Biller, B. M. K., Korbonits, M., Popovic, V., Luger, A., Strasburger, C. J., Chanson, P., Medic-Stojanoska, M., Schopohl, J., Zakrzewska, A., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00665 · Cited by 105
Fleseriu, M., Christ‐Crain, M., Langlois, F., Gadelha, M. R., & Melmed, S. K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00342-8 · Cited by 141
Obesity, growth hormone and weight loss
Rasmussen, M. H. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.017 · Cited by 114
Dimopoulou, C., Schopohl, J., Rachinger, W., Buchfelder, M., Honegger, J., Reincke, M., & Stalla, G. K. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0634 · Cited by 110
Hypopituitarism: Clinical Features, Diagnosis, and Management
Toogood, A. A., & Stewart, P. M. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.004 · Cited by 120
Kelly, D. F., Chaloner, C., Evans, D., Mathews, A., Cohan, P., Wang, C., Swerdloff, R., Sim, M.-S., Lee, J., Wright, M. J., et al. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3212 · Cited by 101
Ameri, P., Giusti, A., Boschetti, M., Bovio, M., Teti, C., Leoncini, G., Ferone, D., Murialdo, G., & Minuto, F. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0510 · Cited by 103
Wagenmakers, M. A. E. M., Netea-Maier, R. T., Prins, J. B., Dekkers, T., den Heijer, M., & Hermus, A. R. M. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0308 · Cited by 101
Pituitary Stem Cell Update and Potential Implications for Treating Hypopituitarism
Castinetti, F., Davis, S. W., Brue, T. C., & Camper, S. A. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0011 · Cited by 107
Interactions between vitamin D and IGF‐I: from physiology to clinical practice
Ameri, P., Giusti, A., Boschetti, M., Murialdo, G., Minuto, F., & Ferone, D. (2013) · Clinical Endocrinology · doi:10.1111/cen.12268 · Cited by 99
Growth Hormone (GH) and Cardiovascular System
Caicedo, D., Díaz, Ó., Devesa, P., & Devesa, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010290 · Cited by 108
Hypopituitarism After Stereotactic Radiosurgery for Pituitary Adenomas
Xu, Z., Vance, M. L., Schlesinger, D. J., & Sheehan, J. P. (2012) · Neurosurgery · doi:10.1227/neu.0b013e3182846e44 · Cited by 99
Self-citationHazem, A., Elamin, M. B., Bancos, I., Malaga, G., Prutsky, G., Domecq, J. P., Elraiyah, T. A., Abu Elnour, N. O., Prevost, Y., Almandoz, J. P., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0558 · Cited by 97
Approach to the Growth Hormone-Deficient Child during Transition to Adulthood
Radovick, S., & DiVall, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0167 · Cited by 96
Diagnosis of adult GH deficiency
Ghigo, E., Aimaretti, G., & Corneli, G. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2007.07.004 · Cited by 103
Torstveit, M. K., Ackerman, K. E., Constantini, N., Holtzman, B., Koehler, K., Mountjoy, M. L., Sundgot-Borgen, J., & Melin, A. (2023) · British Journal of Sports Medicine · doi:10.1136/bjsports-2023-106932 · Cited by 100
Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults
Giustina, A., Barkan, A. L., Chanson, P., Grossman, A. B., Hoffman, A. R., Ghigo, E., Casanueva, F. F., Colao, A., Lamberts, S. W. J., Sheppard, M., et al. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03349263 · Cited by 100
Growth hormone replacement therapy in patients with traumatic brain injury
Moreau, O. K., Cortet-Rudelli, C., Yollin, E., Merlen, E., Daveluy, W., & Rousseaux, M. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2705 · Cited by 94
Barake, M., Klibanski, A., & Tritos, N. A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3921 · Cited by 102
Dichtel, L. E., Yuen, K. C. J., Bredella, M. A., Gerweck, A. V., Russell, B. M., Riccio, A. D., Gurel, M. H., Sluss, P. M., Biller, B. M. K., & Miller, K. K. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2830 · Cited by 94
Hamrahian, A. H., Yuen, K. C. J., Gordon, M. B., Pulaski-Liebert, K. J., Bena, J., & Biller, B. M. K. (2016) · Pituitary · doi:10.1007/s11102-016-0712-7 · Cited by 92
Growth hormone therapy in children; research and practice – A review
Collett‐Solberg, P. F., Jorge, A. A. L., Boguszewski, M. C. D. S., Miller, B. S., Choong, C. S., Cohen, P., Hoffman, A. R., Luo, X., Radovick, S., & Saenger, P. H. (2018) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2018.12.004 · Cited by 107
“Several guidelines for the transition phase have been published elsewhere [59,135,136,137].”
BackgroundDevelopment of early diagnosis of Parkinson's disease: Illusion or reality?
Ugrumov, M. V. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13429 · Cited by 104
Sánchez-Ortiga, R., Klibanski, A., & Tritos, N. A. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04303.x · Cited by 90
Diagnosis and treatment of growth hormone deficiency in adults
Kargi, A. Y., & Merriam, G. R. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.77 · Cited by 95
Self-citationThe complex relationship between obesity and the somatropic axis: The long and winding road
Savastano, S., Somma, C. D., Barrea, L., & Colao, A. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.09.002 · Cited by 94
Endocrine evaluation of erectile dysfunction
Sansone, A., Romanelli, F., Gianfrilli, D., & Lenzi, A. (2014) · Endocrine · doi:10.1007/s12020-014-0254-6 · Cited by 94
Hartman, M. L., Xu, R., Crowe, B. J., Robison, L. L., Erfurth, E. M., Kleinberg, D. L., Zimmermann, A. G., Woodmansee, W. W., Cutler, G. B., Chipman, J. J., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2684 · Cited by 88
Corneli, G., Di Somma, C., Prodam, F., Bellone, J., Bellone, S., Gasco, V., Baldelli, R., Rovere, S., Schneider, H. J., Gargantini, L., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0384 · Cited by 87
Radiation-induced hypopituitarism
Fernandez, A., Brada, M., Zabuliene, L., Karavitaki, N., & Wass, J. A. H. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-08-0231 · Cited by 84
Yuen, K. C. J., Biller, B. M. K., Molitch, M. E., & Cook, D. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0299 · Cited by 84
Self-citationNielsen, E. H., Lindholm, J., Laurberg, P. T., Bjerre, P., Christiansen, J. S., Hagen, C., Juul, S., Jørgensen, J., Kruse, A., & Stochholm, K. (2007) · Pituitary · doi:10.1007/s11102-007-0018-x · Cited by 87
Pituitary dysfunction after blast traumatic brain injury: The UK BIOSAP study
Baxter, D., Sharp, D. J., Feeney, C., Papadopoulou, D., Ham, T. E., Jilka, S., Hellyer, P. J., Patel, M. C., Bennett, A. N., Mistlin, A., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23958 · Cited by 81
“releasing hormone (GHRH)–arginine test and=or insulin tolerance test (ITT).(10,22,23) ACTH deficiency was confirmed with an ITT or metyrapone stimulation test, together with a cortisol day curve.”
MethodCossu, G., Jouanneau, E., Cavallo, L. M., Elbabaa, S. K., Giammattei, L., Starnoni, D., Barges-Coll, J., Cappabianca, P., Beneš, V., Başkaya, M. K., et al. (2020) · Acta Neurochirurgica · doi:10.1007/s00701-020-04265-1 · Cited by 95
Garcia, J. M., Swerdloff, R., Wang, C., Kyle, M., Kipnes, M., Biller, B. M. K., Cook, D., Yuen, K. C. J., Bonert, V., Dobs, A., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1157 · Cited by 81
Self-citationTreatment of growth hormone deficiency in children, adolescents and at the transitional age
Richmond, E. J., & Rogol, A. D. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.11.005 · Cited by 99
Endocrine Manifestations in a Monocentric Cohort of 64 Patients With Erdheim-Chester Disease
Courtillot, C., Laugier‐Robiolle, S., Aubart, F. C., Leban, M., Renard‐Penna, R., Drier, A., Charlotte, F., Amoura, Z., Touraine, P. A., & Haroche, J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3357 · Cited by 87
Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks
Díez, J. J., Sangiao-Alvarellos, S., & Cordido, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030893 · Cited by 81
Manetti, L., Lupi, I., Morselli, L. L., Albertini, S., Cosottini, M., Grasso, L., Genovesi, M., Pinna, G., Mariotti, S., Bogazzi, F., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2748 · Cited by 79
Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs
Yuen, K. C. J., Miller, B. S., Boguszewski, C. L., & Hoffman, A. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.637209 · Cited by 63
Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency
Mazziotti, G., Doga, M., Frara, S., Maffezzoni, F., Porcelli, T., Cerri, L., Maroldi, R., & Giustina, A. (2016) · Endocrine · doi:10.1007/s12020-015-0738-z · Cited by 78
Effects of Growth Hormone on Bone
Tritos, N. A., & Klibanski, A. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.008 · Cited by 94
A review of guidelines for use of growth hormone in pediatric and transition patients
Cook, D. M., & Rose, S. R. (2012) · Pituitary · doi:10.1007/s11102-011-0372-6 · Cited by 81
Matsumoto, R., Fukuoka, H., Iguchi, G., Nishizawa, H., Bando, H., Suda, K., Takahashi, M., & Takahashi, Y. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.07.002 · Cited by 90
Growth Hormone’s Effect on Adipose Tissue: Quality versus Quantity
Berryman, D. E., & List, E. O. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081621 · Cited by 84
Yuen, K. C. J., Johannsson, G., Ho, K. K. Y., Miller, B. S., Bergadá, I., & Rogol, A. D. (2023) · Endocrine Connections · doi:10.1530/ec-22-0504 · Cited by 97
Role and Importance of IGF-1 in Traumatic Brain Injuries
Mangiola, A., Vigo, V., Anile, C., BONIS, P. D., Marziali, G., & Lofrese, G. (2015) · BioMed Research International · doi:10.1155/2015/736104 · Cited by 81
Metadata
- Authors
- Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L.
- Affiliations
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of Washington (US)
- University of Virginia (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-06
- Volume
- 96
- Issue
- 6
- Pages
- 1587-1609
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2090627812
- Semantic Scholar
- 82180f0f73f275a6a0e865c2c46af465e9dc1fc8
- Cited by
- 1,047
- References
- 207
- Citations by year
- 2026: 31 · 2025: 43 · 2024: 46 · 2023: 53 · 2022: 59 · 2021: 61 · 2020: 59 · 2019: 59 · 2018: 64 · 2017: 56 · 2016: 66 · 2015: 63 · 2014: 61 · 2013: 75 · 2012: 42
- FWCI
- 57.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- adult growth hormone deficiency, growth hormone therapy, body composition, exercise capacity, skeletal integrity, quality of life, treatment risks and benefits
- MeSH terms
- Adult, Dwarfism, Pituitary, Humans, Evidence-Based Medicine, Human Growth Hormone, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.